DIURNAL BLOOD PRESSURE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Issue:
4
Year:
2016
Estimation of diurnal blood pressure (BP) variability in patients with systemic lupus erythematosus established a relationship of intracardiac hemodynamic variables to diurnal BP monitoring parameters.
Keywords:
rheumatology
systemic lupus erythematosus
hypertension
diurnal blood pressure
References:
- Bojtsov S.A. Vzaimosvjazi arterioskleroza, ateroskleroza i arterial' noj gipertonii – staryj vopros v svete novyh dannyh // Ter. arh. – 2009; 81 (12): 5–11.
- Chazova I.E., Oschepkova E.V. Rezul'taty realizatsii programmy po bor' be s arterial'noj gipertoniej v Rossii v 2002–2012 // Ter. arh. – 2013; 85 (1): 4–10.
- Danilov N.M., Chazova I.E., Savchenko A.P. Renovaskuljarnaja gipertenzija: diagnostika i lechenie // Sistemnye gipertenzii. – 2009; 1: 71–3.
- Gogin E.E. Vybor lechenija u bol'nyh arterial'noj gipertoniej-terapija simptomaticheskaja i bazisnaja, standartnaja i situatsionnaja. Treatment of hypertension // Ter. arh. – 2012; 84 (4): 41–6.
- Belenkov Ju.N., Privalova E.V., Danilogorskaja Ju.A. Remodelirovanie sosudistogo rusla u bol'nyh arterial'noj gipertenziej: vozmozhnosti dia-gnostiki i korrektsii // Kardiologija. – 2012; 52 (6): 67–71.
- Zaharova E.G., Fursov A.N., Potehin M.I. Izmenenie techenija giperto nicheskoj bolezni za poslednie 25 let // Klin. med. – 2013; 91 (8): 36–40.
- Rothwell P., Howard S., Doln E. et al. Prognostic significance of visit-to visit variability, maximum systolic blood pressure, and episodic hypertension // Lancet. – 2010; 375: 895–905.
- Ostroumova O.D. Variabel'nost' arterial'nogo davlenija i risk oslozhnenij pri arterial'noj gipertonii // Ter. arh. – 2012; 84 (10): 91–7.Karpov Ju.A. Novye Rossijskie rekomendatsii po arterial'noj giper tonii – prioritet kombinirovannoj terapii // Ter. arh. – 2012; 84 (1): 61–4.
- Webb A., Fischer U., Mehta Z. et al. Effects of antihypertensive-drug class on interindividual variation in BP and risk of stroke: a systematic rewiew and meta-analysis // Lancet. – 2010; 375: 906–15.
- Rothwell P., Webb A. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: A systematic review // Stroke. – 2011; 42: 2860–5.
- Demina A.B., Radenska-Lopovok S.G., Folomeeva O.M. i dr. Prichiny smerti bol'nyh s revmaticheskimi zabolevanijami v Moskve // Ter. arh. – 2005; 77 (4): 77–82.
- Popkova T.V., Novikova D.S., Nasonov E.L. Kardiovaskuljarnye fakto ry riska pri revmaticheskih zabolevanijah: svjaz' s vospaleniem // Bolezni serdtsa i sosudov. – 2010; 2: 46–53.
- Wajed J., Ahmad Y., Duttington P. et al. Prevention of cardiovascular disease in systemic lupus erythematosus – proposed guidelines for risk factor management // Rheumatology. – 2004; 43: 7–12.
- Barnes E., Narain S., Naranjo A. et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk // Lupus. – 2005; 14 (8): 576–82.
- Yang L., Tao J., Wang Y. et al. Prevalence and correlation of conventional 16. and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients // J. Eur. Acad. Dermatol. Venerol. – 2011; 26: 95–101.
- Sinicato N., da Silva Cardoso P., Appenzeller S. Risk factors in cardiovascular disease in systemic lupus erthematosus // Curr. Cardiol. Rev. – 2013; 9 (1): 15–9.
- Tso T., Huang W., Huang H. et al. Relationship of plasma interleukin-18 concentrations to traditional and nontraditional cardiovascular risk factors in patients with systemic lupus erythematosus // Rheumatology. – 2006; 45: 1148–53.
- Haque S., Mirjafari H., Bruce I. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus // Curr. Opin. Lipidol. – 2008; 19: 338–43.